Kedua-dua ujian mengesan keradangan usus yang didorong oleh neutrofil, tetapi kalprotektin biasanya merupakan alat pemantauan kuantitatif yang lebih berguna. Keputusan yang betul ialah keputusan yang mengubah keputusan klinikal seterusnya—bukan yang melabelkan anda dengan IBD.
- Kalprotektin di bawah 150 µg/g biasanya meyakinkan pada orang dewasa yang disyaki IBS apabila tiada ciri amaran.
- Laktorin ialah protein neutrofil; banyak ujian kuantitatif menggunakan kurang daripada 7.25 µg/g sebagai negatif, tetapi takat potong makmal berbeza-beza.
- Penanda najis tinggi menunjukkan keradangan usus, bukan diagnosis spesifik; jangkitan, NSAID, divertikulitis dan neoplastik kolorektal boleh meningkatkan kedua-duanya.
- Calprotectin sempadan sebanyak 50–150 µg/g selalunya memerlukan sampel ulangan selepas 2–6 minggu berbanding kolonoskopi segera.
- Kalprotektin melebihi 250 µg/g meningkatkan kebimbangan untuk keradangan mukosa aktif dan biasanya memerlukan semakan klinikal, ujian jangkitan najis atau perancangan endoskopi.
- Keputusan normal dapat mengurangkan kemungkinan penyakit radang usus (IBD) kolonis aktif tetapi tidak dapat mengecualikan penyakit Crohn usus kecil secara bersendirian dengan pasti.
- Pemantauan IBD menggunakan gejala serta biomarker, CRP, penanda anemia, pengimejan dan endoskopi; tiada penanda najis yang secara bersendirian mendiagnosis serangan.
- Gejala yang mendesak seperti najis hitam, darah ketara yang berterusan, demam, sakit teruk, pitam atau dehidrasi memerlukan penilaian perubatan tanpa mengira keputusan penanda.
Penanda najis manakah yang patut anda pilih dahulu?
Kalprotektin najis biasanya merupakan penanda keradangan najis pilihan pertama kerana ia tersedia secara meluas, kuantitatif, dan mempunyai peranan terkuat dalam membezakan penyakit radang usus yang berkemungkinan daripada gejala usus berfungsi. Ujian laktoferin najis keputusan adalah alternatif yang munasabah apabila ia adalah ujian yang disahkan secara tempatan, tetapi memesan kedua-duanya pada mulanya jarang mengubah penjagaan.
Bagi seseorang yang mengalami najis cair selama 6 minggu, kekejangan, dan tiada penurunan berat badan atau pendarahan rektum, saya biasanya akan mulakan dengan kalprotektin ditambah ujian jangkitan sasaran berbanding kolonoskopi. Keputusan di bawah 50 µg/g menjadikan keradangan kolonis yang ketara kurang berkemungkinan, manakala keputusan yang meningkat dengan jelas memberikan sebab untuk menyiasat lebih lanjut. Garis panduan AGA untuk cirit-birit berair kronik menyokong kalprotektin atau laktoperoksidase sebagai ujian saringan untuk keadaan radangan (Smalley et al., 2019).
Pilih laktoperoksidase apabila perkhidmatan gastroenterologi anda menggunakannya secara konsisten, apabila makmal melaporkan nilai kuantitatif yang disahkan, atau apabila ia digabungkan dengan ujian cirit-birit berjangkit. Jangan pilihnya kerana ia kelihatan lebih spesifik: kedua-dua protein dilepaskan apabila neutrofil memasuki lumen usus. Isu praktikalnya ialah sama ada doktor anda boleh membandingkan keputusan dengan sampel anda sebelum ini menggunakan ujian yang sama.
Kantesti ialah seorang Penganalisis ujian darah AI yang meletakkan keputusan berkaitan seperti hemoglobin, CRP, albumin dan indeks besi bersama dengan laporan penanda najis; ia tidak menggantikan ujian najis atau diagnosis doktor. Jika keletihan disertai cirit-birit, ujian darah untuk cirit-birit boleh membantu mengenal pasti dehidrasi, anemia, atau kehilangan elektrolit yang mengubah keperluan mendesak.
Peraturan praktikal yang berguna
Gunakan satu penanda yang disahkan dahulu, ulangi penanda yang sama apabila keputusan adalah sempadan atau apabila memantau rawatan, dan rizab ujian berganda untuk soalan gastroenterologi tertentu. Menukar ujian di tengah-tengah susulan mewujudkan arah aliran yang ketara yang mungkin merupakan bunyi makmal dan bukannya biologi.
Apa yang sebenarnya dikesan oleh kalprotektin najis
Kalprotektin mengukur protein pengikat kalsium dan zink yang dilepaskan terutamanya daripada neutrofil dalam saluran usus. Kepekatan najis yang lebih tinggi mencerminkan migrasi neutrofil ke dalam usus, yang biasa berlaku dalam IBD aktif tetapi juga berlaku dengan beberapa keadaan bukan IBD.
Kalprotektin adalah kompleks protein S100A8/S100A9, dan ia kekal agak stabil dalam najis selama beberapa hari pada suhu bilik—salah satu sebab ia berfungsi dengan baik sebagai ujian pengumpulan di rumah. Kekuatan biologinya adalah tempatan: tidak seperti CRP, ia mencerminkan aktiviti selular dalam lumen usus berbanding tindak balas fasa akut seluruh badan. Oleh itu, CRP normal tidak membatalkan keputusan kalprotektin yang tinggi.
Dalam amalan dewasa, makmal biasa mengklasifikasikan kurang daripada 50 µg/g sebagai normal dan lebih daripada 150–250 µg/g sebagai semakin serasi dengan keradangan usus aktif. Ini adalah ambang keputusan, bukan sempadan biologi universal. Sesetengah perkhidmatan Eropah menggunakan 100 µg/g sebagai ambang rujukan, manakala selang rujukan pediatrik dan khusus ujian boleh berbeza dengan ketara.
Saya telah melihat seorang pesakit berusia 28 tahun dengan kalprotektin 680 µg/g, CRP normal, dan akhirnya kolitis ulseratif terhad kepada rektum dan kolon sigmoid. Corak itu tidak luar biasa: keradangan mukosa tempatan boleh aktif tanpa isyarat sistemik yang kuat. fecal calprotectin range guide explains why the laboratory’s own method and units should stay attached to every result.
Apa yang dikesan secara berbeza oleh laktorin najis
Lactoferrin detects another neutrophil-derived protein and answers nearly the same biological question as calprotectin: is there active intestinal neutrophil inflammation? It does not identify ulcerative colitis, Crohn’s disease, bacterial colitis, or another cause on its own.
Lactoferrin is an iron-binding glycoprotein stored in neutrophil secondary granules and released during activation. A positive qualitative fecal lactoferrin test is useful because it argues against uncomplicated IBS in the right clinical setting. Quantitative assays vary: one commonly used method defines a negative value as less than 7.25 µg/g, so never apply a calprotectin cutoff to a lactoferrin report.
The evidence does not show that lactoferrin is categorically superior. In a diagnostic meta-analysis, Wang and colleagues found fecal lactoferrin had pooled sensitivity of 82% and specificity of 95% for distinguishing IBD from non-IBD controls, although accuracy estimates shift with disease prevalence and study design (Wang et al., 2015). That impressive specificity still does not convert a positive result into an IBD diagnosis.
A positive lactoferrin result is especially worth discussing when diarrhoea began abruptly after travel, antibiotics, contaminated food exposure, or contact with someone unwell. In those situations, clinicians usually add pathogen testing rather than jumping straight to an IBD label. Our guide to keputusan kultur najis covers what a negative or mixed-growth report can and cannot settle.
Cara membaca takat potong tanpa reaksi berlebihan
A calprotectin value below 50 µg/g is usually normal for adults, 50–150 µg/g is often an indeterminate zone, and values above 250 µg/g raise concern for active inflammation. Lactoferrin uses assay-specific cutoffs, commonly a qualitative positive or a quantitative threshold near 7.25 µg/g.
The 50 µg/g calprotectin threshold is designed for sensitivity: it catches most clinically significant inflammatory disease at the cost of some false positives. The 250 µg/g threshold is more useful for specificity and for monitoring established IBD. Between them lies the frustrating middle, where medication exposure, recent gastroenteritis, age, and trajectory matter more than a single number.
A change from 72 to 94 µg/g is often less meaningful than a change from 85 to 430 µg/g, particularly if both samples were tested by the same laboratory. Stool consistency can influence extraction and biological variation is real. Dr. Thomas Klein’s practical advice is to record NSAID use, recent infection, menstrual contamination, and collection date before interpreting a modest rise.
For a disciplined approach to serial values, compare the sample date with symptoms and related labs rather than treating every flagged result as disease progression. Our 3-10 mEq/L tanpa kalium; 8-16 mEq/L dengan kalium explains the same principle of reference change and analytic variation in laboratory medicine.
Mengapa kedua-dua penanda boleh tinggi tanpa IBD
Elevated stool inflammation markers occur with enteric infection, NSAID exposure, diverticulitis, colorectal neoplasia, microscopic colitis and IBD. The result confirms an inflammatory signal; it does not disclose the cause, location, duration, or severity by itself.
Non-steroidal anti-inflammatory drugs can raise fecal calprotectin, sometimes substantially, by increasing intestinal permeability and causing small mucosal injuries. Ibuprofen, naproxen and diclofenac matter; a clinician may suggest withholding them if medically safe before repeating the test. Do not stop prescribed aspirin, anticoagulants, or pain medicines without asking the prescriber first.
Acute bacterial gastroenteritis may produce calprotectin values above 500 µg/g and a positive lactoferrin, which is why a stool pathogen panel can be more informative than an urgent colonoscopy in the first days of illness. Conversely, giardiasis may cause prolonged diarrhoea with less striking neutrophilic marker elevation. The symptom timeline often carries more diagnostic weight than patients expect.
Kantesti ialah seorang perkhidmatan tafsiran ujian makmal AI that can flag an inflammation pattern such as low hemoglobin, low albumin, thrombocytosis and raised CRP for clinician review, but those blood findings do not prove the source is intestinal. For people with blood in the stool, FIT follow-up and colonoscopy timing is a separate issue from calprotectin and should not be delayed.
Bilakah keputusan normal masih boleh terlepas penyakit
Normal calprotectin or lactoferrin makes active colonic inflammation less likely, but it cannot fully exclude Crohn’s disease, particularly mild or isolated small-bowel disease. A normal result also does not explain persistent weight loss, iron-deficiency anemia, nocturnal diarrhoea, or recurrent visible bleeding.
Small-bowel Crohn’s disease can shed less neutrophil protein into a stool sample than extensive colitis, especially when lesions are proximal or mild. This is one reason symptoms and alarm features overrule a reassuring number. The ECCO-ESGAR diagnostic guideline recommends integrating biomarkers with ileocolonoscopy and cross-sectional imaging when IBD remains clinically suspected (Maaser et al., 2019).
A 46-year-old with calprotectin of 38 µg/g, ferritin of 7 ng/mL, and progressive fatigue deserves evaluation for gastrointestinal blood loss or malabsorption even if bowel frequency is normal. In my experience, the combination of iron deficiency and unexplained symptoms is much more consequential than a single low stool marker. Read our low ferritin and gut clues for the usual next laboratory questions.
Celiac disease, bile acid diarrhoea, pancreatic insufficiency and many medication effects may cause symptoms with normal stool inflammation markers. A normal test is therefore a fork in the road toward non-inflammatory diagnoses, not a declaration that symptoms are psychological or unimportant.
Apa yang perlu dilakukan dengan keputusan kalprotektin yang sempadan
A borderline fecal calprotectin result of 50–150 µg/g is commonly repeated after 2–6 weeks if symptoms are stable and there are no alarm features. The repeat should use the same laboratory method and should be timed away from a recent gastrointestinal infection where possible.
Before retesting, clinicians review NSAIDs, proton-pump inhibitors, antibiotics, acute infections, strenuous endurance exercise and age-related risk. There is no universally agreed washout interval for every medicine. A pragmatic plan is often 2 weeks after an acute illness has settled, provided symptoms do not signal a need for earlier care.
If the repeat falls from 118 to 32 µg/g and symptoms settle, invasive testing may be avoidable. If it rises from 96 to 310 µg/g, the direction adds useful evidence even before an endoscopy result arrives. This is why a single borderline value should rarely trigger panic—or false reassurance.
kami borderline calprotectin follow-up guide lays out the questions to bring to a primary-care or gastroenterology appointment. A short symptom diary with stool frequency, nighttime waking, fever and medication dates is usually more useful than obsessively checking food triggers.
Cara pakar klinikal menggunakan penanda selepas IBD didiagnosis
In established IBD, calprotectin is most useful for tracking objective intestinal inflammation and helping decide whether symptoms represent a flare, infection, IBS overlap, or treatment failure. Lactoferrin can also follow activity, but calprotectin has more guideline-supported thresholds for treat-to-target monitoring.
Symptoms and mucosal activity frequently diverge. A patient with ulcerative colitis may feel well while calprotectin climbs from 80 to 360 µg/g, or have urgent bowel motions from bile acid malabsorption while calprotectin remains 28 µg/g. The 2023 AGA ulcerative colitis biomarker guideline advises combining symptoms with biomarkers rather than relying on either alone (Singh et al., 2023).
For remission monitoring, many clinicians view less than 150 µg/g as reassuring, while more than 150 µg/g may warrant repeat testing, endoscopy, or treatment review depending on symptoms and prior disease behaviour. In active symptomatic ulcerative colitis, more than 250 µg/g supports ongoing inflammation. Cutoffs are guides, not instructions to alter biologic treatment without specialist input.
Kantesti AI ialah an platform tafsiran biomarker AI that organizes blood-test trends around a patient’s reported treatment dates; it cannot assess stool endoscopic severity from a number alone. Patients taking biologics should also understand which blood safety tests monitor treatment and which symptoms require prompt contact with their IBD team.
Kesalahan pengumpulan dan pemasaan menjejaskan keputusan
Collection quality affects stool marker interpretation because a contaminated, delayed, or poorly sampled specimen can be rejected or produce a less reliable measurement. Most laboratories want a small stool portion placed into the supplied sterile container without toilet water or urine.
Loose stool is usually acceptable for calprotectin and lactoferrin testing; do not wait for a formed sample if diarrhoea is the clinical problem. Avoid collecting from toilet water, and tell the laboratory if the sample includes visible menstrual blood. Storage instructions vary by kit, but many allow short room-temperature transport because calprotectin is comparatively stable.
Sampling a day after a marathon, a bout of gastroenteritis, or colonoscopy bowel preparation may answer the wrong question. Endurance exercise can transiently increase gut permeability and provoke gastrointestinal symptoms. If you are an endurance athlete without red flags, consider timing collection away from a major event; our panduan makmal atlet ketahanan explains why context changes test interpretation.
The thing is, a perfect collection does not make a nonspecific biomarker specific. A high-quality sample improves confidence in the measurement; it cannot replace the clinical history, examination, and differential diagnosis.
Ujian darah manakah yang menjadikan penanda najis lebih berguna
A CBC, CRP, ferritin, albumin, kidney function and celiac serology often add more clinical value to a raised stool marker than ordering a second stool inflammation protein. The concerning pattern is not any one abnormality but several results that point toward inflammation, malabsorption, or blood loss.
Low hemoglobin, ferritin below 15 ng/mL, albumin below the laboratory reference range, raised platelets, or raised CRP can strengthen concern for clinically meaningful bowel disease. None is diagnostic of IBD. In fact, CRP may remain normal in mild ulcerative colitis, and ferritin can look falsely normal when inflammation raises it as an acute-phase protein.
Kantesti ialah seorang Alat analisis ujian darah berkuasa AI that reads a CBC, iron studies and CRP in the same clinical frame, including whether a changing hemoglobin level might justify earlier review. Dr. Thomas Klein routinely cautions that an isolated CRP of 12 mg/L is nonspecific, whereas CRP 12 mg/L plus falling albumin and a calprotectin of 740 µg/g is a much more actionable cluster.
For patients whose iron values seem contradictory, our iron studies research guide explains transferrin saturation and ferritin during inflammation. A CBC result guide can also help you identify whether anemia is microcytic, inflammatory, or mixed.
Bilakah memesan kedua-dua ujian mungkin munasabah
Ordering calprotectin and lactoferrin together is usually unnecessary, but it can be reasonable when a specialist is reconciling discordant symptoms, a prior assay cannot be repeated, or a local pathway requires confirmation. Concordant results modestly increase confidence in an inflammatory signal; discordant results usually trigger review, not arithmetic averaging.
A high calprotectin with negative lactoferrin may reflect assay timing, a result near the cutoff, specimen heterogeneity, or analytical differences. A low calprotectin with positive lactoferrin deserves the same disciplined response: verify collection, review the exact assay, check symptoms and test for infection when appropriate. Neither combination has a validated shortcut to diagnosis.
Dual testing can also be useful in research settings where a protocol prespecifies both biomarkers. That is different from routine patient care, where duplicate testing can add cost without improving decisions. Ask the ordering clinician a simple question: “What will we do differently if the second test is positive?”
If a report looks internally inconsistent, use our panduan ujian kualitatif berbanding kuantitatif to understand why “positive” and “high” are not interchangeable laboratory statements. Consistency of method matters more than collecting every available marker.
Apa yang sebenarnya mengesahkan atau menolak IBD
IBD is diagnosed through a synthesis of symptoms, ileocolonoscopy with tissue sampling, histology, laboratory tests, and sometimes MRI or CT enterography—not from calprotectin or lactoferrin alone. Stool markers help decide who needs these investigations and whether inflammation may be changing over time.
Colonoscopy allows direct assessment of the terminal ileum and colon and permits tissue examination for chronic inflammatory features, infection, microscopic colitis, dysplasia, and other causes. Imaging is particularly valuable when Crohn’s disease may involve small bowel beyond the reach of a standard colonoscopy. A stool marker is a triage signal, not a microscopic diagnosis.
Do not confuse a fecal immunochemical test with either inflammatory marker. FIT detects human hemoglobin and is used primarily in colorectal cancer screening or lower-GI bleeding pathways, whereas calprotectin and lactoferrin detect neutrophil products. Our comparison of FIT and FOBT explains why a negative inflammation marker does not substitute for recommended cancer screening.
As of September 4, 2026, no major gastroenterology guideline recommends diagnosing Crohn’s disease or ulcerative colitis from a single stool biomarker threshold. That restraint protects patients from both missed disease and unnecessary lifelong diagnostic labels.
Simptom yang mengatasi mana-mana keputusan ujian najis
Persistent visible rectal bleeding, black tarry stool, severe abdominal pain, fever, fainting, dehydration, rapidly worsening weakness, or unintended weight loss need timely medical assessment regardless of calprotectin or lactoferrin. A normal result should never be used to wait out a potentially urgent symptom pattern.
The urgent concern is physiology, not the label on a laboratory report. Frequent watery diarrhoea can produce low potassium, acute kidney injury, and orthostatic symptoms before an inflammation marker returns. Adults with inability to keep fluids down, confusion, fainting, or minimal urine output should seek urgent care.
New bowel symptoms after age 50, a strong family history of colorectal cancer, and iron-deficiency anemia alter the threshold for colon evaluation even when calprotectin is low. A stool marker does not assess cancer risk comprehensively. Our mucus in stool red-flag guide distinguishes common benign patterns from symptoms that need examination.
Children, pregnant people, older adults, and people using immune-suppressing medicines need individualized triage because their baseline risks differ. If you are unsure whether symptoms are urgent, contacting a local clinician or urgent-care service is safer than trying to interpret a number in isolation.
Perbualan praktikal yang perlu diadakan selepas keputusan anda
The most useful follow-up question is: “Does this result change my need for infection testing, repeat testing, imaging, or endoscopy?” Bringing the exact value, assay name, symptom timeline, medicines, and previous results makes that conversation faster and more clinically precise.
Bring a list of the previous 14 days: stool frequency, overnight symptoms, fever, weight change, travel, antibiotics, NSAIDs, and family history. A calprotectin of 180 µg/g after a 3-day febrile diarrhoeal illness calls for a different plan than the same result after 4 months of nocturnal diarrhoea and weight loss.
Kantesti AI can help you organize accompanying blood reports before an appointment, but diagnosis and treatment decisions belong with the clinician who can examine you and arrange definitive testing. Our untuk pengesahan perubatan explains how clinical oversight and source checking are built into responsible laboratory interpretation.
For complex cases, ask who will own the follow-up and when you should expect a repeat result or referral decision. The clinicians on our Lembaga Penasihat Perubatan emphasize that a documented plan beats a vague instruction to “recheck later,” especially when inflammation markers and anemia move in the same direction.
Kesimpulan utama yang berfokus pada keputusan
Choose calprotectin first in most settings, use lactoferrin when it is your service’s validated alternative, and do not assume either result diagnoses IBD. A low result shifts attention toward functional and non-inflammatory causes, while a persistently high result identifies people who may need infection testing, specialist review, or endoscopy.
For uncomplicated chronic diarrhoea, one normal marker—calprotectin below 50 µg/g or a negative lactoferrin according to that laboratory—can reduce the likelihood of active inflammatory disease. For a value above 250 µg/g or a positive lactoferrin with persistent symptoms, the next question is cause, not certainty. Infection, medicine exposure, IBD, and other inflammatory conditions remain on the list.
Most patients find the ambiguity hardest in the 50–150 µg/g calprotectin zone. In my experience, the best next step is usually a carefully timed repeat, not a dietary cleanse, self-directed steroid use, or an internet diagnosis. Keep the same laboratory where feasible so the trend is interpretable.
Kantesti’s panduan teknologi AI describes how our systems preserve laboratory context while highlighting questions for medical review. The safe use of any AI interpretation is the same here: use it to prepare for a better clinical conversation, never to override red flags or replace diagnostic care.
Soalan Lazim
Adakah kalprotektin lebih baik daripada laktiferin untuk mengesan IBD?
Kalsiproktektin selalunya lebih digemari untuk IBD yang disyaki kerana ia tersedia secara meluas sebagai ujian kuantitatif dan mempunyai ambang pemantauan yang biasa digunakan seperti kurang daripada 50 µg/g dan lebih daripada 250 µg/g. Laktoperin juga merupakan penanda najis yang berasal daripada neutrofil yang berguna dan boleh berfungsi dengan baik apabila makmal menggunakan ujian yang sah. Tiada penanda yang mengesahkan IBD, kerana jangkitan, NSAID, divertikulitis dan keadaan usus lain boleh meningkatkan kedua-duanya. Ujian yang lebih baik biasanya ialah ujian yang boleh ditafsirkan oleh doktor anda bersama-sama dengan simptom dan diulang menggunakan kaedah makmal yang sama.
Berapakah paras kalprotektin yang membimbangkan?
Tahap kalprotektin tinja di bawah 50 µg/g umumnya meyakinkan untuk orang dewasa tanpa gejala membimbangkan, manakala 50–150 µg/g sering dianggap borderline dan mungkin diulang selepas 2–6 minggu. Nilai melebihi 150–250 µg/g lebih membimbangkan untuk keradangan usus, dan tahap melebihi 250 µg/g selalunya memerlukan semakan klinikal atau ujian lanjut. Tindakan tepat bergantung pada ujian, gejala, usia, penggunaan NSAID dan sama ada nilai tersebut meningkat. Nilai 600 µg/g selepas cirit-birit bakteria akut mungkin mempunyai makna yang berbeza daripada 600 µg/g semasa beberapa bulan gejala kronik.
Bolehkah IBS menyebabkan calprotectin atau laktToTensorin yang tinggi?
IBS tanpa komplikasi biasanya tidak menyebabkan peningkatan fecal calprotectin atau laktosferin kerana IBS tidak menghasilkan keradangan usus yang didorong oleh neutrofil. Peningkatan calprotectin ringan antara 50 dan 150 µg/g boleh berlaku akibat jangkitan baru-baru ini, penggunaan NSAID, faktor berkaitan usia, atau variasi ujian, jadi ia tidak secara automatik menyingkirkan IBS. Laktosferin positif atau calprotectin melebihi 250 µg/g harus mendorong penilaian untuk punca keradangan atau jangkitan dan bukannya menganggap IBS. IBS dan IBD boleh wujud bersama, yang merupakan satu lagi sebab mengapa gejala dan trend adalah penting.
Can a normal calprotectin rule out Crohn's disease?
Keputusan kalprotektin yang normal mengurangkan kemungkinan IBD kolon yang aktif tetapi tidak dapat menyingkirkan penyakit Crohn sepenuhnya, terutamanya penyakit Crohn usus kecil yang ringan atau terpencil. Nilai di bawah 50 µg/g tidak seharusnya mengatasi ciri-ciri amaran seperti anemia kekurangan zat besi, penurunan berat badan, cirit-birit nokturnal, pendarahan berterusan atau sejarah keluarga yang kuat. Doktor boleh menggunakan ileokolonoskopi, MR enterografi atau penilaian kapsul apabila kecurigaan klinikal kekal tinggi. Keputusan ini paling baik dianggap sebagai satu bukti pelarasan kebarangkalian berbanding ujian penyingkiran akhir.
Perlukah saya mengulang keputusan calprotectin yang borderline?
Keputusan calprotectin yang borderline iaitu 50–150 µg/g selalunya diulang selepas 2–6 minggu apabila simptom stabil dan tiada ciri-ciri amaran. Sebelum mengulang ujian, doktor biasanya menyemak sejarah gastroenteritis baru-baru ini, penggunaan NSAID, antibiotik dan keadaan pengumpulan sampel, kerana setiap faktor boleh mempengaruhi nilai keputusan. Gunakan kaedah ujian makmal yang sama jika boleh, kerana keputusan daripada kaedah yang berbeza mungkin tidak boleh dibandingkan secara terus. Keputusan yang meningkat ke arah atau melebihi 250 µg/g secara amnya mempunyai kepentingan klinikal yang lebih besar berbanding peningkatan tahap rendah yang stabil.
Bolehkah antibiotik menjejaskan calprotectin dan laktferin najis?
Antibiotik boleh mempengaruhi penanda keradangan najis secara tidak langsung dengan merawat, mencetuskan, atau berlaku serentak dengan cirit-birit berjangkit dan dengan mengubah mikrobioma usus. Seseorang yang mengalami cirit-birit berkaitan antibiotik perlu dinilai untuk punca seperti Clostridioides difficile dan bukannya mentafsirkan peningkatan calprotectin atau lactoferrin positif sebagai IBD. Tiada tempoh masa yang boleh dipercayai secara universal untuk menunggu selepas antibiotik sebelum ujian; masa bergantung pada gejala dan persoalan klinikal. Cirit-birit, demam, atau sakit perut yang berterusan selepas antibiotik memerlukan ujian yang dikendalikan oleh doktor berbanding rawatan sendiri.
Dapatkan Analisis Ujian Darah Berkuasa AI Hari Ini
Sertai lebih 2 juta pengguna di seluruh dunia yang mempercayai Kantesti untuk analisis ujian makmal segera dan tepat. Muat naik keputusan ujian darah anda dan terima tafsiran menyeluruh biomarker 15,000+ dalam beberapa saat.
📚 Penerbitan Penyelidikan Dirujuk
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Urobilinogen dalam Ujian Air Kencing: Panduan Analisis Urin Lengkap 2026. Zenodo.. Kantesti Penyelidikan Perubatan AI.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo.. Kantesti Penyelidikan Perubatan AI.
📖 Rujukan Perubatan Luaran
Singh S et al. (2023). AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology.
⚕️ Penafian Perubatan
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Pengalaman
Semakan klinikal yang diketuai oleh doktor terhadap aliran kerja tafsiran makmal.
Kepakaran
Fokus perubatan makmal tentang bagaimana biomarker berkelakuan dalam konteks klinikal.
Kewibawaan
Ditulis oleh Dr. Thomas Klein dengan semakan oleh Dr. Sarah Mitchell dan Prof. Dr. Hans Weber.
Kebolehpercayaan
Tafsiran berasaskan bukti dengan laluan susulan yang jelas untuk mengurangkan kebimbangan.